1. Home
  2. MDXH vs DTF Comparison

MDXH vs DTF Comparison

Compare MDXH & DTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • DTF
  • Stock Information
  • Founded
  • MDXH 2003
  • DTF 1991
  • Country
  • MDXH Belgium
  • DTF United States
  • Employees
  • MDXH N/A
  • DTF N/A
  • Industry
  • MDXH
  • DTF Investment Managers
  • Sector
  • MDXH
  • DTF Finance
  • Exchange
  • MDXH Nasdaq
  • DTF Nasdaq
  • Market Cap
  • MDXH 78.3M
  • DTF 79.4M
  • IPO Year
  • MDXH 2021
  • DTF N/A
  • Fundamental
  • Price
  • MDXH $2.65
  • DTF $11.41
  • Analyst Decision
  • MDXH Strong Buy
  • DTF
  • Analyst Count
  • MDXH 2
  • DTF 0
  • Target Price
  • MDXH $7.50
  • DTF N/A
  • AVG Volume (30 Days)
  • MDXH 41.3K
  • DTF 21.1K
  • Earning Date
  • MDXH 11-06-2024
  • DTF 01-01-0001
  • Dividend Yield
  • MDXH N/A
  • DTF 3.64%
  • EPS Growth
  • MDXH N/A
  • DTF N/A
  • EPS
  • MDXH N/A
  • DTF 0.44
  • Revenue
  • MDXH $80,741,000.00
  • DTF N/A
  • Revenue This Year
  • MDXH $24.45
  • DTF N/A
  • Revenue Next Year
  • MDXH $15.22
  • DTF N/A
  • P/E Ratio
  • MDXH N/A
  • DTF $24.34
  • Revenue Growth
  • MDXH 45.51
  • DTF N/A
  • 52 Week Low
  • MDXH $0.35
  • DTF $10.29
  • 52 Week High
  • MDXH $4.64
  • DTF $11.19
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 42.01
  • DTF 67.92
  • Support Level
  • MDXH $2.84
  • DTF $11.30
  • Resistance Level
  • MDXH $2.96
  • DTF $11.32
  • Average True Range (ATR)
  • MDXH 0.12
  • DTF 0.07
  • MACD
  • MDXH -0.04
  • DTF 0.00
  • Stochastic Oscillator
  • MDXH 21.74
  • DTF 91.80

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

About DTF DTF Tax-Free Income 2028 Term Fund Inc.

DTFTax-Free Income Inc is a diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax consistent with preservation of capital. The fund seeks to achieve its investment objective by investing in a diversified portfolio of investment-grade tax-exempt obligations.

Share on Social Networks: